NCT06944951View on ClinicalTrials.gov

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device PROCTOeze® PLUS in the Relief of Haemorrhoidal Disease and Anal Irritation Symptoms

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

January 17, 2025

Study Completion Date

January 17, 2025

Conditions
Haemorrhoidal Disease
Interventions
DEVICE

Hydrophilic emulsion for the relief of haemorroidal symptoms

Administration for 2 weeks of PROCTOeze® PLUS - a soft and light hydrophilic emulsion able to provide symptomatic relief of haemorrhoids and anal irritation.

Trial Locations (1)

Unknown

C.M.I. Sisu Lucia Cristina, Craiova

All Listed Sponsors
lead

Biokosmes Srl

INDUSTRY

NCT06944951 - Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device PROCTOeze® PLUS in the Relief of Haemorrhoidal Disease and Anal Irritation Symptoms | Biotech Hunter | Biotech Hunter